Avalo Therapeutics AVTX Balance Sheet (2014-2026)

NASDAQ AVTX
$19.24 +0.24 (+1.24%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Avalo Therapeutics Quarterly Balance Sheet

Periods 48 quarters
Latest Jun 2026

Avalo Therapeutics reported total assets of $490.78M and total liabilities of $42.12M for the quarter ended Jun 2026, up 287.7% year over year. This balance sheet covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
71.51M54.59M38.47M11.25M16.94M13.17M16.69M6.31M10.18M7.42M110.18M93.43M81.86M134.55M125.05M42.29M26.96M15.86M24.99M85.38M
Receivables - NetNet Receivables
1.44M1.06M0.94M0.90M0.80M0.04M
Receivables - OtherOther Receivables
2.48M1.26M-2.29M1.31M1.31M0.60M-1.06M0.01M1.54M-1.40M-0.10M-0.10M1.00M-0.39M
Receivables
3.91M2.32M-1.36M2.21M2.11M0.60M0.04M
Raw Materials
Finished Goods
Inventory
0.02M0.04M0.03M0.02M0.02M0.02M0.02M0.02M
Prepaid Assets
1.41M2.37M2.68M1.89M1.12M1.29M1.63M1.14M0.94M0.84M1.00M2.44M3.25M4.33M1.83M1.90M2.14M6.91M6.68M7.61M
Current Assets
77.01M61.84M43.66M15.02M19.45M16.42M19.25M7.52M12.66M8.39M111.21M95.89M86.15M138.89M126.94M115.19M113.85M105.29M88.83M407.93M
Non-Current Assets
Property, Plant & Equipment (Net)
1.41M2.69M2.60M2.57M2.51M2.41M2.44M2.18M2.07M1.97M1.88M1.78M1.67M1.21M0.95M0.69M0.54M0.46M0.38M0.29M
Long-Term Investments
71.88M
Goodwill
14.41M14.41M14.41M14.41M14.41M14.41M14.41M14.41M14.41M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M
Intangibles
0.30M0.04M
Goodwill & Intangibles
14.71M14.45M14.41M14.41M14.41M14.41M14.41M14.41M14.41M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M10.50M
Long-Term Deferred Tax
Other Non-Current Assets
0.23M1.00M0.23M0.23M0.18M0.13M0.13M0.13M0.13M0.13M0.13M0.13M0.13M0.13M0.13M0.21M0.21M0.21M0.18M0.18M
Non-Current Assets
18.35M18.37M18.24M17.20M17.10M16.95M16.98M16.72M16.61M12.60M12.52M12.41M12.31M11.84M11.58M11.40M11.25M11.17M11.06M82.85M
Assets
95.36M80.21M61.90M32.22M36.55M33.37M36.23M24.23M29.27M20.99M123.73M108.31M98.45M150.73M138.52M126.58M125.10M116.46M99.89M490.78M
Liabilities
Current Liabilities
Accounts Payables
3.57M3.37M3.76M2.16M1.45M2.88M5.57M0.75M0.79M0.45M0.92M0.65M1.81M0.28M0.68M2.37M0.47M0.14M0.36M3.35M
Notes Payables
2.56M5.93M9.30M14.12M0.36M0.36M0.37M
Payables
3.57M3.37M3.76M2.16M4.01M8.81M14.86M14.87M0.79M0.45M0.92M0.65M1.81M0.64M1.04M2.74M0.47M0.14M0.36M3.35M
Accumulated Expenses
15.46M16.52M14.14M13.23M13.70M13.21M8.27M7.59M5.22M4.17M7.38M7.89M7.03M6.32M4.57M6.52M7.50M12.80M11.24M17.78M
Other Accumulated Expenses
0.65M0.38M0.44M0.28M0.40M0.51M0.45M0.61M0.21M0.24M0.33M0.33M0.33M0.33M0.33M0.33M
Short term Debt
Current Taxes
Current Deferred Revenue
0.44M0.09M0.11M
Total Current Liabilities
19.04M19.89M17.89M15.39M18.15M22.11M23.25M22.45M6.00M4.62M215.70M96.40M60.67M6.96M5.62M9.26M7.97M12.94M11.60M21.13M
Non-Current Liabilities
Non-Current Debt
32.48M32.83M33.18M18.71M16.50M13.49M10.47M
Preferred Stock Liabilities
11.46M11.46M1.66M
Liabilities from Discontinued Operations
0.01M
Operating Leases
Non-Current Deferred Tax Liability
0.13M0.11M0.12M0.13M0.13M0.14M0.15M0.16M0.16M0.15M0.16M0.17M0.15M1.43M0.28M0.29M0.30M0.43M0.45M0.46M
Other Non-Current Liabilities
1.40M2.30M2.36M1.94M1.79M4.83M5.01M5.05M4.95M5.55M5.67M10.71M11.81M8.48M7.74M10.26M23.16M18.00M17.52M18.53M
Total Non-Current Liabilities
53.65M54.83M53.20M36.24M36.78M39.45M37.49M26.15M9.62M8.14M219.14M99.75M63.91M9.22M8.17M11.75M10.39M15.41M14.04M23.59M
Total Liabilities
55.05M57.13M55.56M38.17M38.58M44.28M42.50M31.20M14.57M13.69M224.81M110.46M75.72M17.70M15.91M22.01M33.55M33.41M31.57M42.12M
Shareholder's Equity
Total Debt
32.48M32.83M33.18M18.71M19.07M19.42M19.77M14.12M0.36M0.36M0.37M
Common Equity
40.31M23.08M6.34M-5.95M-2.03M-10.91M-6.27M-6.97M14.70M7.30M-112.54M-13.61M21.08M133.03M122.61M104.57M91.55M83.05M68.32M448.66M
Liabilities and Shareholders Equity
95.36M80.21M61.90M32.22M36.55M33.37M36.23M24.23M29.27M20.99M123.73M108.31M98.45M150.73M138.52M126.58M125.10M116.46M99.89M490.78M
Retained Earnings
283.17M285.24M290.45M-297.20M-294.01M-303.82M-313.80M-321.74M341.47M342.44M-456.42M-357.96M355.99M503.29M506.02M508.77M526.29M531.49M536.45M953.70M
Preferred Shares
Treasury Shares
0.02M0.02M0.01M2.002.002.002.002.002.00